Genomic profiling by circulating tumor DNA in patients with hormone receptor-positive/HER2-negative advanced breast cancer: Prevalence of actionable mutations across treatment lines

Rodrigo Dienstmann, Márcio Luiz Martins Júnior, Breno Jeha Araújo, Cristiano Augusto Andrade de Resende, Rafael Duarte Paes, Christopher Lucas Negrete, Leandro Moreno Silveira da Silva, Daniela Jessica Pereira, Gustavo de Oliveira Bretas, Larissa Muller Gomes, Maria Cristina Figueroa Magalhaes, Max Senna Mano, Aline Coelho Goncalves, Ana Carolina Teixeira Pires, Andrea Morais Borges, Jorge Henrique Santos Leal, Juliano Dazzi Rigoni, Stefany Cardoso Faria, Alessandra Menezes Morelle, Ana Carolina Silva Barbosa, Andrea Arredondo Farias, Cristiane Alves Mendes Parizzi, Geila Ribeiro Nunez, Leandro Jonata de Carvalho Oliveira, Rafael Brant Costa, Jéssica Vieria de Assis, Carolina de Bustamante Fernandes, Daniela Tiaki Uehara, Erica Aparecida de Assis, Renata de Godoy e Silva, Nathalia Pellegrini Correa, Jacqueline de Siqueira Roberto, Giovana Ravizzoni Onzi, Leonard Medeiros da Silva, Fernanda Christtanini Koyama, Angelica Nogueira Rodrigues

Open source

DOI
10.1016/j.ctarc.2026.101443
Published
2026
Container
Cancer Treatment and Research Communications
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ctarc.2026.101443,
  title = {Genomic profiling by circulating tumor DNA in patients with hormone receptor-positive/HER2-negative advanced breast cancer: Prevalence of actionable mutations across treatment lines},
  author = {Rodrigo Dienstmann and Márcio Luiz Martins Júnior and Breno Jeha Araújo and Cristiano Augusto Andrade de Resende and Rafael Duarte Paes and Christopher Lucas Negrete and Leandro Moreno Silveira da Silva and Daniela Jessica Pereira and Gustavo de Oliveira Bretas and Larissa Muller Gomes and Maria Cristina Figueroa Magalhaes and Max Senna Mano and Aline Coelho Goncalves and Ana Carolina Teixeira Pires and Andrea Morais Borges and Jorge Henrique Santos Leal and Juliano Dazzi Rigoni and Stefany Cardoso Faria and Alessandra Menezes Morelle and Ana Carolina Silva Barbosa and Andrea Arredondo Farias and Cristiane Alves Mendes Parizzi and Geila Ribeiro Nunez and Leandro Jonata de Carvalho Oliveira and Rafael Brant Costa and Jéssica Vieria de Assis and Carolina de Bustamante Fernandes and Daniela Tiaki Uehara and Erica Aparecida de Assis and Renata de Godoy e Silva and Nathalia Pellegrini Correa and Jacqueline de Siqueira Roberto and Giovana Ravizzoni Onzi and Leonard Medeiros da Silva and Fernanda Christtanini Koyama and Angelica Nogueira Rodrigues},
  year = {2026},
  journal = {Cancer Treatment and Research Communications},
  doi = {10.1016/j.ctarc.2026.101443},
  url = {https://doi.org/10.1016/j.ctarc.2026.101443}
}

RIS

TY  - JOUR
TI  - Genomic profiling by circulating tumor DNA in patients with hormone receptor-positive/HER2-negative advanced breast cancer: Prevalence of actionable mutations across treatment lines
AU  - Rodrigo Dienstmann
AU  - Márcio Luiz Martins Júnior
AU  - Breno Jeha Araújo
AU  - Cristiano Augusto Andrade de Resende
AU  - Rafael Duarte Paes
AU  - Christopher Lucas Negrete
AU  - Leandro Moreno Silveira da Silva
AU  - Daniela Jessica Pereira
AU  - Gustavo de Oliveira Bretas
AU  - Larissa Muller Gomes
AU  - Maria Cristina Figueroa Magalhaes
AU  - Max Senna Mano
AU  - Aline Coelho Goncalves
AU  - Ana Carolina Teixeira Pires
AU  - Andrea Morais Borges
AU  - Jorge Henrique Santos Leal
AU  - Juliano Dazzi Rigoni
AU  - Stefany Cardoso Faria
AU  - Alessandra Menezes Morelle
AU  - Ana Carolina Silva Barbosa
AU  - Andrea Arredondo Farias
AU  - Cristiane Alves Mendes Parizzi
AU  - Geila Ribeiro Nunez
AU  - Leandro Jonata de Carvalho Oliveira
AU  - Rafael Brant Costa
AU  - Jéssica Vieria de Assis
AU  - Carolina de Bustamante Fernandes
AU  - Daniela Tiaki Uehara
AU  - Erica Aparecida de Assis
AU  - Renata de Godoy e Silva
AU  - Nathalia Pellegrini Correa
AU  - Jacqueline de Siqueira Roberto
AU  - Giovana Ravizzoni Onzi
AU  - Leonard Medeiros da Silva
AU  - Fernanda Christtanini Koyama
AU  - Angelica Nogueira Rodrigues
PY  - 2026
JO  - Cancer Treatment and Research Communications
DO  - 10.1016/j.ctarc.2026.101443
UR  - https://doi.org/10.1016/j.ctarc.2026.101443
ER  - 

APA

Dienstmann, R., Júnior, M. L. M., Araújo, B. J., Resende, C. A. A. D., Paes, R. D., Negrete, C. L., Silva, L. M. S. D., Pereira, D. J., Bretas, G. D. O., Gomes, L. M., Magalhaes, M. C. F., Mano, M. S., Goncalves, A. C., Pires, A. C. T., Borges, A. M., Leal, J. H. S., Rigoni, J. D., Faria, S. C., Morelle, A. M., Barbosa, A. C. S., Farias, A. A., Parizzi, C. A. M., Nunez, G. R., Oliveira, L. J. D. C., Costa, R. B., Assis, J. V. D., Fernandes, C. D. B., Uehara, D. T., Assis, E. A. D., Silva, R. D. G. E., Correa, N. P., Roberto, J. D. S., Onzi, G. R., Silva, L. M. D., Koyama, F. C., & Rodrigues, A. N. (2026). Genomic profiling by circulating tumor DNA in patients with hormone receptor-positive/HER2-negative advanced breast cancer: Prevalence of actionable mutations across treatment lines. Cancer Treatment and Research Communications. https://doi.org/10.1016/j.ctarc.2026.101443

Source records